The total return over the past 12 months is +10.92% vs. +16.94% for the S&P 500. So far it's up +2.21% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +10.92% | +6.59% | (10.73%) | +5.98% | N/A | N/A |
| Total Return CAGR | +10.92% | +6.59% | (10.73%) | +5.98% | N/A | N/A |
| Revenue CAGR | (7.27%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (195.58%) | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (189.41%) | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Kura Oncology, Inc. (KURA)
| Year | Start price | End price | KURA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $10.39 | $10.62 | +2.21% | +14.51% | (12.30%) |
| 2025 | $8.71 | $10.39 | +19.29% | +17.72% | +1.57% |
| 2024 | $14.38 | $8.71 | (39.43%) | +24.89% | (64.32%) |
| 2023 | $12.41 | $14.38 | +15.87% | +26.19% | (10.32%) |
| 2022 | $14.00 | $12.41 | (11.36%) | (18.17%) | +6.81% |
| 2021 | $32.66 | $14.00 | (57.13%) | +28.74% | (85.87%) |
| 2020 | $13.75 | $32.66 | +137.53% | +18.37% | +119.16% |
| 2019 | $14.04 | $13.75 | (2.07%) | +31.22% | (33.29%) |
| 2018 | $15.30 | $14.04 | (8.24%) | (4.56%) | (3.68%) |
| 2017 | $5.90 | $15.30 | +159.32% | +21.70% | +137.62% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
